France
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -7.07 M
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
2 |
USD -2.75 M
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
3 |
USD -2.59 M
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
4 |
USD -1.43 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
5 |
USD -1.42 M
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
6 |
USD -1.29 M
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
7 |
USD -1.21 M
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
8 |
USD -853.73 K
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
9 |
USD -677.00 K
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
10 |
USD -596.02 K
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
11 |
USD -380.79 K
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
12 |
USD -362.03 K
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
13 |
USD -292.49 K
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
14 |
USD -290.29 K
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
15 |
USD -256.07 K
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
|
16 |
USD -203.09 K
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
17 |
USD -172.19 K
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
18 |
USD -97.13 K
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
19 |
USD -46.84 K
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
The Clinical Trials company in France with the highest Capital Expenditure is Crossject SA (Paris Stock Exchange: ALCJ.PA) at USD -7.07 M.
The Clinical Trials company in France with the lowest Capital Expenditure is Predilife S.A. (Paris Stock Exchange: ALPRE.PA) at USD -46.84 K.
The top 10 Clinical Trials companies in France by Capital Expenditure are Crossject SA, Genfit S.A., Innate Pharma S.A., Median Technologies SA, Advicenne S.A., MedinCell S.A., MaaT Pharma SA, Novacyt S.A., DBV Technologies S.A. and Inventiva S.A..
The bottom 10 Clinical Trials companies in France by Capital Expenditure are Predilife S.A., Aelis Farma SA, Adocia SA, Affluent Medical SA, OSE Immunotherapeutics SA, Valbiotis SA, ABIVAX SA, Nanobiotix S.A., AB Science S.A. and Inventiva S.A..